15806-42-5 Usage
General Description
N-CETYLMALEAMIDE ACID, also known as N-cetyl maleamic acid, is a chemical compound primarily used in the production of plastics, coatings, and adhesives. It is a type of maleamic acid with a cetyl side chain, making it a long-chain fatty acid derivative. This chemical is often utilized as a crosslinking agent in polymer materials, improving their mechanical and thermal properties. Additionally, it can act as a dispersing agent in pigment preparations and as a flame retardant in various materials. N-CETYLMALEAMIDE ACID is known for its low toxicity and is compatible with a wide range of polymers, making it a valuable additive in the industry.
Check Digit Verification of cas no
The CAS Registry Mumber 15806-42-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,8,0 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 15806-42:
(7*1)+(6*5)+(5*8)+(4*0)+(3*6)+(2*4)+(1*2)=105
105 % 10 = 5
So 15806-42-5 is a valid CAS Registry Number.
InChI:InChI=1/C20H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18-21-19(22)16-17-20(23)24/h16-17H,2-15,18H2,1H3,(H,21,22)(H,23,24)
15806-42-5Relevant articles and documents
Compound, application thereof, platinum coordination complex and liposome thereof
-
Paragraph 0190-0194, (2017/08/31)
The invention relates to the field of medicines, in particular to a compound, application thereof, a platinum coordination complex and liposome thereof. The platinum coordination complex disclosed by the invention can be well combined with a membrane material of the liposome, so that encapsulation efficiency and drug loading capacity of the liposome are improved; furthermore, the platinum coordination complex disclosed by the invention contains carboxyl and has pH sensitivity; the carboxyl trends to be deprotonated in lower pH value environment (such as tumor tissues), so that release of medicine in the tumor tissues is improved, and a curing effect of medicine is improved. Experiments show that the liposome disclosed by the invention can reduce toxic and side effects of the medicine and improve medicine effects.
